Answers are grounded in this paper and cite their sources.
Transcription regulation depends on interactions between enhancers and gene promoters, which often occur over large genomic distances. The molecular drivers of long-range enhancer-promoter interactions remain poorly understood. Enhancers themselves are known to be transcribed into non-coding RNAs, but the function of these transcripts is unclear. Here, we use acute genetic and chemical perturbations of transcription elongation and termination to study the role of non-coding RNA in enhancer-promoter interactions. By integrating high-resolution 3D genome mapping, transcriptomics, proteomics, biochemistry and live-cell super-resolution imaging in these perturbation contexts, we demonstrate that a strong increase in RNA molecules at enhancers disrupts their long-range interactions with gene promoters, whereas decreased RNA levels lead to stabilization of these interactions. Using separation-of-function perturbations, we show that this regulatory function of RNA is independent from the process of transcription and the proteins recruited to initiate transcription. Functionally, we show that RNA-mediated disruption of enhancer-promoter interactions is associated with reduced transcription of target genes, indicating a regulatory feedback mechanism. Together, our results uncover an additional regulatory principle of enhancer-promoter interactions mediated by non-coding RNA.
No takes yet. Share an insight, caveat, or question.
Sagropoulou et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: